Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Federated Kaufmann Small Cap Fund Class A Shares (FKASX)

Net Asset Value
1 Day
Overall Morningstar Rating
Small growth
Style or Category
Sales Expenses
Expense Ratio
Morningstar Risk Rating™
Investment Objective The investment seeks to provide capital appreciation. The fund invests primarily in the common stocks of small companies that are traded on national security exchanges- the NASDAQ stock market and on the over-the-counter market. It will normally invest at least 80% of its net assets (which include the amount of any borrowing for investment purposes) in small companies and will notify shareholders at least 60 days in advance of any change in its investment policies that would permit the fund to normally invest less than 80% of its net assets in investments in small companies.


1 month+3.62% 3 years+16.47%
3 months+6.77% 5 years+16.13%
1 year+31.12% Since inception+13.77%
Data through --

Peer Comparisonvs. Small growth

Performance 5-yr return+16.13%+13.02%
Expense ratio1.59%1.29%
Risk 5 year sharpe ratio0.960.95
Net assets$791.4M$974.5M
Average market cap$1.6B$3.7B
Average P/E--29.8
Portfolio turnover48%48%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyFederated
Fund manager & tenureHans Utsch / 14 Years
Minimal initial investment$1,500.00
Minimum IRA investment$250.00


U.S. stock75.47%
International stock10.18%
Fixed income8.61%
Top 5 Sectors
Portfolio weighting
Healthcare 22.72%
Consumer service 12.39%
Industrial materials 10.86%
Hardware 9.36%
Business service 8.91%
Top 10 Holdings
Portfolio weighting
VEEV Veeva Systems Inc2.19%
CORT Corcept Therapeutics Inc1.77%
FND Floor & Decor Holdings Inc1.56%
GTT GTT Communications Inc1.46%
SIGM Sigma Designs Inc1.45%
KRNT Kornit Digital Ltd1.34%
DVAX Dynavax Technologies Corp1.33%
MSCC Microsemi Corp1.29%
NERV Minerva Neurosciences Inc1.28%
MIME Mimecast Ltd1.27%